Skip to main content
See every side of every news story
Published loading...Updated

Why Genmab Stock Was Marching Higher Today @themotleyfool #stocks $GMAB $^GSPC

Summary by The Motley Fool
Key PointsTwo prognosticators published updates on the biotech after it announced a major acquisition.It should soon be the owner of fellow European biotech Merus.10 stocks we like better than Genmab A/s › One day after announcing a sizable acquisition, Denmark-based biotech Genmab (NASDAQ: GMAB) was doing well on the stock exchange Tuesday. A pair of analysts weighed in with bullish new takes on the company, helping push it to a nearly 5% price…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Tuesday, September 30, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal